Clinical Trial Update: Buprenorphine Pharmacometric Open Label Research Study of Drug Exposure [Phase 1, Phase 2]

View source ↗

Summary

Open-label pharmacometric study evaluating buprenorphine exposure in neonatal abstinence syndrome with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Abstinence Syndrome
• Neonatal Opiate Withdrawal Syndrome

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Neonatal Abstinence Syndrome, Neonatal Opiate Withdrawal Syndrome | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-02-11